Genetic models for transforming growth factor β superfamily signaling in ovarian follicle development

Molecular and Cellular Endocrinology

Volumn 225, Issue 1-2, 2004, Pages 83-91

  Pangas, Stephanie A ^a   Matzuk, Martin M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Fertility; Ovary; Reproduction

Indexed keywords

ACTIVIN A; BINDING PROTEIN; BONE MORPHOGENETIC PROTEIN 15; GROWTH DIFFERENTIATION FACTOR 9; LIGAND; TRANSFORMING GROWTH FACTOR BETA;

CELL GROWTH; CONFERENCE PAPER; GENE INTERACTION; GENE LOCUS; GENETIC MODEL; KNOCKOUT GENE; LABORATORY; MODEL; NONHUMAN; OOCYTE DEVELOPMENT; OVARY FOLLICLE DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; FEMALE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, GENETIC; OVARIAN FOLLICLE; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTORS;

EID: 4644327904     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2004.02.017     Document Type: Conference Paper

References (120)

1. Ahn K., Mishina Y., Hanks M.C., Behringer R.R., Crenshaw E.B. III BMPR-IA signaling is required for the formation of the apical ectodermal ridge and dorsal-ventral patterning of the limb. Development. 128:2001;4449
2. Assoian R.K., Komoriya A., Meyers C.A., Miller D.M., Sporn M.B. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J. Biol. Chem. 258:1983;155-160
3. Attisano L., Wrana J.L. Signal transduction by the TGF-beta superfamily. Science. 296:2002;1646-1647
4. Baarends W.M., Uilenbroek J.T., Kramer P., Hoogerbrugge J.W., van Leeuwen E.C., Themmen A.P., Grootegoed J.A. Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology. 136:1995;4951-4962
5. Balemans W., Van Hul W. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev. Biol. 250:2002;231-250
6. Behringer R.R., Finegold M.J., Cate R.L. Mullerian-inhibiting substance function during mammalian sexual development. Cell. 79:1994;415-425
7. Beppu H., Kawabata M., Hamamoto T., Chytil A., Minowa O., Noda T., Miyazono K. BMP type II receptor is required for gastrulation and early development of mouse embryos. Dev. Biol. 221:2000;249-258
8. Bisgrove B., Essner J., Yost H. Regulation of midline development by antagonism of lefty and nodal signaling. Development. 126:1999;3253-3262
9. Bondestam J., Kaivo-oja N., Kallio J., Groome N., Hyden-Granskog C., Fujii M., Moustakas A., Jalanko A., ten Dijke P., Ritvos O. Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells. Mol. Cell. Endocrinol. 195:2002;79-88
10. Brown C.W., Houston-Hawkins D.E., Woodruff T.K., Matzuk M.M. Insertion of Inhbb into the Inhba locus rescues the Inhba-null phenotype and reveals new activin functions. Nat. Genet. 25:2000;453-457
11. Cameron V.A., Nishimura E., Mathews L.S., Lewis K.A., Sawchenko P.E., Vale W.W. Hybridization histochemical localization of activin receptor subtypes in rat brain, pituitary, ovary, and testis. Endocrinology. 134:1994;799-808
12. Carabatsos M.J., Elvin J., Matzuk M.M., Albertini D.F. Characterization of oocyte and follicle development in growth differentiation factor-9-deficient mice. Dev. Biol. 204:1998;373-384
13. Chang H., Brown C.B., Matzuk M.M. Genetic analysis of the mammalian transforming growth factor-β superfamily. Endocrinol. Rev. 23:2002;787-823
14. Chang H., Huylebroeck D., Verschueren K., Guo Q., Matzuk M.M., Zwijsen A. Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development. 126:1999;1631-1642
15. Chang H., Lau A.L., Matzuk M.M. Studying TGF-β superfamily signaling by knockouts and knockins. Mol. Cell. Endocrinol. 180:2001;39-46
16. Chang H., Matzuk M.M. Smad5 is required for mouse primordial germ cell development. Mech. Dev. 104:2001;61-67
17. Chang H., Zwijsen A., Vogel H., Huylebroeck D., Matzuk M.M. Smad5 is essential for left-right asymmetry in mice. Dev. Biol. 219:2000;71-78
18. Chen Y.-G., Hata A., Lo R.S., Wotton D., Shi Y., Pavletich N., Massague J. Determinants of specificity in TGF-beta signal transduction. Genes Dev. 12:1998;2144-2152
19. Chen Y.G., Massague J. Smad1 recognition and activation by the ALK1 group of transforming growth factor-beta family receptors. J. Biol. Chem. 274:1999;3672-3677
20. Coerver K.A., Woodruff T.K., Finegold M.J., Mather J., Bradley A., Matzuk M.M. Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice. Mol. Endocrinol. 10:1996;534-543
21. Datto M.B., Frederick J.P., Pan L., Borton A.J., Zhuang Y., Wang X.-F. Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol. Cell. Biol. 19:1999;2495
22. Davis A.A., Matzuk M.M., Reh T.A. Activin A promotes progenitor differentiation into photoreceptors in rodent retina. Mol. Cell. Neurosci. 15:2000;11-21
23. Dickson M., Martin J., Cousins F., Kulkarni A., Karlsson S., Akhurst R. Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development. 121:1995;1845
24. Dong J., Albertini D.F., Nishimori K., Kumar T.R., Lu N., Matzuk M.M. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature. 383:1996;531-535
25. Drummond A.E., Le M.T., Ethier J.-F., Dyson M., Findlay J.K. Expression and localization of activin receptors, Smads, and betaglycan to the postnatal rat ovary. Endocrinology. 143:2002;1423-1433
26. Dube J.L., Wang P., Elvin J., Lyons K.M., Celeste A.J., Matzuk M.M. The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol. Endocrinol. 12:1998;1809-1817
27. Dudley A.T., Lyons K., Robertson E.J. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev. 9:1995;2795-2807
28. Dunn N.R., Winnier G.E., Hargett L.K., Schrick J.J., Fogo A.B., Hogan B.L.M. Haploinsufficient phenotypes in Bmp4 heterozygous null mice and modification by mutations in Gli3 and Alx4. Dev. Biol. 188:1997;235-247
29. Durlinger A.L., Kramer P., Karels B., de Jong F.H., Uilenbroek J.T., Grootegoed J.A., Themmen A.P. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology. 140:1999;5789-5796
30. Elvin J.A., Clark A.T., Wang P., Wolfman N.M., Matzuk M.M. Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol. Endocrinol. 13:1999a;1035-1048
31. Elvin J.A., Yan C., Wang P., Nishimori K., Matzuk M.M. Molecular characterization of the follicle defects in the growth differentiation factor 9-deficient ovary. Mol. Endocrinol. 13:1999b;1018-1034
32. Elvin J.A., Yan C., Matzuk M.M. Growth differentiation factor-9 stimulates progesterone synthesis in granulosa cells via a prostaglandin E2/EP2 receptor pathway. Proc. Natl. Acad. Sci. U.S.A. 97:2000a;10288-10293
33. Elvin J.A., Yan C., Matzuk M.M. Oocyte-expressed TGF-β superfamily members in female fertility. Mol. Cell. Endocrinol. 159:2000b;1-5
34. Ferguson C.A., Tucker A.S., Christensen L., Lau A.L., Matzuk M.M., Sharpe P.T. Activin is an essential early mesenchymal signal in tooth development that is required for patterning of the murine dentition. Genes Dev. 12:1998;2636-2649
35. Gazzerro E., Gangji V., Canalis E. Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. J. Clin. Invest. 102:1998;2106-2114
36. Gentry L.E., Lioubin M.N., Purchio A.F., Marquardt H. Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide. Mol. Cell. Biol. 8:1988;4162-4168
37. Goumans M.-J., Valdimarsdottir G., Itoh S., Rosendahl A., Sideras P., ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J. 21:2002;1743-1753
38. Groppe J., Greenwald J., Wiater E., Rodriguez-Leon J., Economides A.N., Kwiatkowski W., Affolter M., Vale W.W., Belmonte J.C., Choe S. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature. 420:2002;636-642
39. Gu Z., Nomura M., Simpson B.B., Lei H., Feijen A., van den Eijnden-van Raaij J., Donahoe P.K., Li E. The type I activin receptor ActRIB is required for egg cylinder organization and gastrulation in the mouse. Genes Dev. 12:1998;844-857
40. Heldin C.H., Miyazono K., ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature. 4:1997;465-471
41. Hill, J.J., Qiu, Y., Hewick, R.M., Wolfman, N.M., 2003. Regulation of myostatin in vivo by GASP-1: a novel protein with protease inhibitor and follistatin domains. Mol. Endocrinol. 2002, 366.
42. Hoodless P.A., Haerry T., Abdollah S., Stapleton M., O'Connor M.B., Attisano L., Wrana J.L. MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell. 85:1996;489-500
43. Imamura T., Takase M., Nishihara A., Oeda E., Hanai J., Kawabata M., Miyazono K. Smad6 inhibits signalling by the TGF-beta superfamily. Nature. 389:1997;622-626
44. Itoh F., Asao H., Sugamura K., Heldin C.-H., ten Dijke P., Itoh S. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads. EMBO J. 20:2001;4132-4142
45. Jhaveri S., Erzurumlu R.S., Chiaia N., Kumar T.R., Matzuk M.M. Defective whisker follicles and altered brainstem patterns in activin and follistatin knockout mice. Mol. Cell. Neurosci. 12:1998;206-219
46. Kaartinen V., Voncken J.W., Shuler C., Warburton D., Bu D., Heisterkamp N., Groffen J. Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat. Genet. 11:1995;415-421
47. Kaivo-Oja N., Bondestam J., Kamarainen M., Koskimies J., Vitt U., Cranfield M., Vuojolainen K., Kallio J.P., Olkkonen V.M., Hayashi M., Moustakas A., Groome N.P., ten Dijke P., Hsueh A.J.W., Ritvos O. Growth differentiation factor-9 induces Smad2 activation and inhibin B production in cultured human granulosa-luteal cells. J. Clin. Endocrinol. Metab. 88:2003;755-762
48. Kameda T., Koike C., Saitoh K., Kuroiwa A., Iba H. Developmental patterning in chondrocytic cultures by morphogenic gradients: BMP induces expression of indian hedgehog and noggin. Genes Cells. 4:1999;175-184
49. Kim R.Y., Robertson E.J., Solloway M.J. Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart. Dev. Biol. 235:2001;449-466
50. Kretzschmar M., Liu F., Hata A., Doody J., Massague J. The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev. 11:1997;984-995
51. Kulkarni A., Huh C., Becker D., Geiser A., Lyght M., Flanders K., Roberts A., Sporn M., Ward J., Karlsson S. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. U.S.A. 90:1993;770
52. Larsson J., Goumans M.J., Sjostrand L.J., van Rooijen M.A., Ward D., Leveen P., Xu X., ten Dijke P., Mummery C.L., Karlsson S. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J. 20:2001;1663-1673
53. Lau A.L., Kumar T.R., Nishimori K., Bonadio J., Matzuk M.M. Activin betaC and betaE genes are not essential for mouse liver growth, differentiation, and regeneration. Mol. Cell. Biol. 20:2000;6127-6137
54. Lawson K.A., Dunn N.R., Roelen B.A.J., Zeinstra L.M., Davis A.M., Wright C.V.E., Korving J.P.W.F.M., Hogan B.L.M. Bmp4 is required for the generation of primordial germ cells in the mouse embryo. Genes Dev. 13:1999;424
55. Lechleider R.J., Ryan J.L., Garrett L., Eng C., Deng C.-x., Wynshaw-Boris A., Roberts A.B. Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion. Dev. Biol. 240:2001;157-167
56. Li Q., Karam S.M., Coerver K.A., Matzuk M.M., Gordon J.I. Stimulation of activin receptor II signaling pathways inhibits differentiation of multiple gastric epithelial lineages. Mol. Endocrinol. 12:1998;181-192
57. Liao W.X., Moore R.K., Otsuka F., Shimasaki S. Effect of intracellular interactions on the processing and secretion of bone morphogenetic protein-15 (BMP-15) and growth and differentiation factor-9. Implications of the aberrant ovarian phenotype of BMP-15 mutant sheep. J. Biol. Chem. 278:2003;3713-3719
58. Lo R.S., Chen Y.G., Shi Y., Pavletich N.P., Massague J. The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF-beta receptors. EMBO J. 17:1998;996-1005
59. Luo G., Hofmann C., Bronckers A.L., Sohocki M., Bradley A., Karsenty G. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev. 9:1995;2808-2820
60. Macias-Silva M., Hoodless P.A., Tang S.J., Buchwald M., Wrana J.L. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J. Biol. Chem. 273:1998;25628-25636
61. Massague J. TGF beta signaling: receptors, transducers, and Mad proteins. Cell. 85:1996;947-950
62. Massague J. TGF-beta signal transduction. Annu. Rev. Biochem. 67:1998;753-791
63. Matunis E., Tran J., Gonczy P., Caldwell K., DiNardo S. Punt and schnurri regulate a somatically derived signal that restricts proliferation of committed progenitors in the germline. Development. 124:1997;4383-4391
64. Matzuk M.M., Finegold M.J., Mather J.P., Krummen L., Lu H., Bradley A. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 91:1994;8817-8821
65. Matzuk M.M., Finegold M.J., Su J.G., Hsueh A.J., Bradley A. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature. 360:1992;313-319
66. Matzuk M.M., Kumar T.R., Bradley A. Different phenotypes for mice deficient in either activins or activin receptor type II. Nature. 374:1995a;356-360
67. Matzuk M.M., Lu N., Vogel H., Sellheyer K., Roop D.R., Bradley A. Multiple defects and perinatal death in mice deficient in follistatin. Nature. 374:1995b;360-363
68. Matzuk M.M., Kumar T.R., Shou W., Coerver K.A., Lau A.L., Behringer R.R., Finegold M.J. Transgenic models to study the roles of inhibins and activins in reproduction, oncogenesis, and development. Recent Prog. Horm. Res. 51:1996;123-154
69. Matzuk M.M., Lamb D.J. Genetic dissection of mammalian fertility pathways. Nat. Med. 8(S1):2002;S41-S49
70. McGrath S.A., Esquela A.F., Lee S.J. Oocyte-specific expression of growth/differentiation factor-9. Mol. Endocrinol. 9:1995;131-136
71. McPherron A.C., Lawler A.M., Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 387:1997;83-90
72. McPherron A.C., Lee S.-J. Double muscling in cattle due to mutations in the myostatin gene. Proc. Natl. Acad. Sci. U.S.A. 94:1997;12457-12461
73. Meno C., Gritsman K., Ohishi S., Ohfuji Y., Heckscher E., Mochida K., Shimono A., Kondoh H., Talbot W.S., Robertson E.J., Schier A.F., Hamada H. Mouse Lefty2 and zebrafish antivin are feedback inhibitors of nodal signaling during vertebrate gastrulation. Mol. Cell. 4:1999;287-298
74. Mishina Y., Crombie R., Bradley A., Behringer R.R. Multiple roles for activin-like kinase-2 signaling during mouse embryogenesis. Dev. Biol. 213:1999;314-326
75. Mishina Y., Rey R., Finegold M.J., Matzuk M.M., Josso N., Cate R.L., Behringer R.R. Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev. 10:1996;2577-2587
76. Mishina Y., Suzuki A., Ueno N., Behringer R.R. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev. 9:1995;3027-3037
77. Miyazawa K., Shinozaki M., Hara T., Furuya T., Miyazono K. Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells. 7:2002;1191-1204
78. Mulheron G.W., Danielpour D., Schomberg D.W. Rat thecal/interstitial cells express transforming growth factor-beta type 1 and 2, but only type 2 is regulated by gonadotropin in vitro. Endocrinology. 129:1991;368-374
79. Nakao A., Afrakhte M., Moren A., Nakayama T., Christian J.L., Heuchel R., Itoh S., Kawabata M., Heldin N.E., Heldin C.H., ten Dijke P. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature. 389:1997a;631-635
80. Nakao A., Imamura T., Souchelnytskyi S., Kawabata M., Ishisaki A., Oeda E., Tamaki K., Hanai J., Heldin C.H., Miyazono K., ten Dijke P. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16:1997b;5353-5362
81. Nomura M., Li E. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature. 393:1998;786-790
82. Onichtchouk D., Chen Y.G., Dosch R., Gawantka V., Delius H., Massague J., Niehrs C. Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature. 401:1999;480-485
83. Oshima M., Oshima H., Taketo M.M. TGF-β receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 179:1996;297-302
84. Otsuka F., Moore R.K., Iemura S.-i., Ueno N., Shimasaki S. Follistatin inhibits the function of the oocyte-derived factor BMP-15. Biochem. Biophys. Res. Commun. 289:2001;961-966
85. Pangas S.A., Rademaker A.W., Fishman D.A., Woodruff T.K. Localization of the activin signal transduction components in normal human ovarian follicles: implications for autocrine and paracrine signaling in the ovary. J. Clin. Endocrinol. Metab. 87:2002;2644-2657
86. Pepinsky, R.B., Sinclair, L.K., Chow, E.P., Mattaliano, R.J., Manganaro, T.F., Donahoe, P.K., Cate, R.L., 1988. Proteolytic processing of mullerian inhibiting substance produces a transforming growth factor-beta-like fragment. J. Biol. Chem. 263, 18961-18964.
87. Plant T.M., Padmanabhan V., Ramaswamy S., McConnell D.S., Winters S.J., Groome N., Midgley A.R. Jr., McNeilly A.S. Circulating concentrations of dimeric inhibin A and B in the male rhesus monkey (Macaca mulatta). J. Clin. Endocrinol. Metab. 82:1997;2617-2621
88. Proetzel G., Pawlowski S.A., Wiles M.V., Yin M., Boivin G.P., Howles P.N., Ding J., Ferguson M.W., Doetschman T. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat. Genet. 11:1995;409-414
89. Rivier J., Spiess J., McClintock R., Vaughan J., Vale W. Purification and partial characterization of inhibin from porcine follicular fluid. Biochem. Biophys. Res. Commun. 133:1985;120-127
90. Roberts A.B., Anzano M.A., Meyers C.A., Wideman J., Blacher R., Pan Y.C., Stein S., Lehrman S.R., Smith J.M., Lamb L.C., Sporn M.B. Purification and properties of a type beta transforming growth factor from bovine kidney. Biochemistry. 22:1981;5692-5698
91. Roberts, A.B., Sporn, M.B., 1990. The transforming growth factor-βs. In: Sporn, M.B., Roberts, A.B. (Eds.), Peptide Growth Factors and Their Receptors, Part I. Springer-Verlag, Berlin, pp. 419-472.
92. Robertson D., Burger H.G., Sullivan J., Cahir N., Groome N., Poncelet E., Franchimont P., Woodruff T., Mather J.P. Biological and immunological characterization of inhibin forms in human plasma. J. Clin. Endocrinol. Metab. 81:1996;669-676
93. Roh J.-S., Bondestam J., Mazerbourg S., Kaivo-Oja N., Groome N., Ritvos O., Hsueh A.J. Growth differentiation factor-9 stimulates inhibin production and activates Smad2 in cultured rat granulosa cells. Endocrinology. 144:2003;172-178
94. Roy S.K., Kole A.R. Transforming growth factor-beta receptor type II expression in the hamster ovary: cellular site(s), biochemical properties, and hormonal regulation. Endocrinology. 136:1995;4610-4620
95. Roy S.K., Kole A.R. Ovarian transforming growth factor-beta (TGF-beta) receptors: in-vitro effects of follicle stimulating hormone, epidermal growth factor and TGF-beta on receptor expression in human preantral follicles. Mol. Hum. Reprod. 4:1998;207-214
96. Sanford L., Ormsby I., Gittenberger-de Groot A., Sariola H., Friedman R., Boivin G., Cardell E., Doetschman T. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development. 124:1997;2659
97. Schmid P., Cox D., Vanderputten H., Mcmaster G.K., Bilbe G. Expression of TGF-betas and TGF-beta type II receptor mRNAs in mouse folliculogenesis: stored maternal TGF-beta2 message in oocytes. Biochem. Biophys. Res. Commun. 201:1994;649-656
98. Shimasaki S., Zachow R.J., Li D., Kim H., Iemura S., Ueno N., Sampath K., Chang R.J., Erickson G.F. A functional bone morphogenetic protein system in the ovary. Proc. Natl. Acad. Sci. U.S.A. 96:1999;7282-7287
99. Shou W., Aghdasi B., Armstrong D.L., Guo Q., Bao S., Charng M.J., Mathews L.M., Schneider M.D., Hamilton S.L., Matzuk M.M. Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12. Nature. 391:1998;489-492
100. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D., Annunziata N., Doetschman T. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 359:1992;399-693
101. Sirard C., de la Pompa J.L., Elia A., Itie A., Mirtsos C., Cheung A., Hahn S., Wakeham A., Schwartz L., Kern S.E., Rossant J., Mak T.W. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev. 12:1998;107
102. Solloway M., Robertson E. Early embryonic lethality in Bmp5Bmp7 double mutant mice suggests functional redundancy within the 60A subgroup. Development. 126:1999;1753
103. Tomic D., Brodie S.G., Deng C., Hickey R.J., Babus J.K., Malkas L.H., Flaws J.A. Smad 3 may regulate follicular growth in the mouse ovary. Biol. Reprod. 66:2002;917
104. Tremblay K.D., Dunn N.R., Robertson E.J. Mouse embryos lacking Smad1 signals display defects in extra-embryonic tissues and germ cell formation. Development. 128:2001;3609
105. Varani S., Elvin J.A., Yan C., DeMayo J., DeMayo F.J., Horton H.F., Byrne M.C., Matzuk M.M. Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility. Mol. Endocrinol. 16:2002;1154-1167
106. Vassalli A., Matzuk M.M., Gardner H.A., Lee K.F., Jaenisch R. Activin/inhibin beta B subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev. 8:1994;414-427
107. Vitt U.A., Mazerbourg S., Klein C., Hsueh A.J.W. Bone morphogenetic protein receptor type II is a receptor for growth differentiation factor-9. Biol. Reprod. 67:2002;473-480
108. Waldrip W.R., Bikoff E.K., Hoodless P.A., Wrana J.L., Robertson E.J. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell. 92:1998;797-808
109. Weiss J., Crowley W.F. Jr., Halvorson L.M., Jameson J.L. Perifusion of rat pituitary cells with gonadotropin-releasing hormone, activin, and inhibin reveals distinct effects on gonadotropin gene expression and secretion. Endocrinology. 132:1993;2307-2311
110. Wiater E., Vale W. Inhibin is an antagonist of bone morphogenetic protein signaling. J. Biol. Chem. 278:2003;7934-7941
111. Winnier G., Blessing M., Labosky P.A., Hogan B.L. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 9:1995;105-116
112. Woodruff T.K., Besecke L.M., Groome N., Draper L.B., Schwartz N.B., Weiss J. Inhibin A and inhibin B are inversely correlated to follicle-stimulating hormone, yet are discordant during the follicular phase of the rat estrous cycle, and inhibin A is expressed in a sexually dimorphic manner. Endocrinology. 137:1996;5463-5467
113. Yan C., Wang P., DeMayo J., DeMayo F.J., Elvin J.A., Carino C., Prasad S.V., Skinner S.S., Dunbar B.S., Dube J.L., Celeste A.J., Matzuk M.M. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol. Endocrinol. 15:2001;854-866
114. Yang X., Castilla L., Xu X., Li C., Gotay J., Weinstein M., Liu P., Deng C. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development. 126:1999a;1571
115. Yang X., Letterio J.J., Lechleider R.J., Chen L., Hayman R., Gu H., Roberts A.B., Deng C. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J. 18:1999b;1280-1291
116. Yang X., Li C., Xu X., Deng C. The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc. Natl. Acad. Sci. U.S.A. 95:1998;3667
117. Zhang Y., Feng X., We R., Derynck R. Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature. 383:1996;168-172
118. Zhao G.Q. Consequences of knocking out BMP signaling in the mouse. Genesis. 35:2003;43-56
119. Zhu Y., Richardson J.A., Parada L.F., Graff J.M. Smad3 mutant mice develop metastatic colorectal cancer. Cell. 94:1998;703-714
120. Zimmerman L.B., De Jesus-Escobar J.M., Harland R.M. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell. 86:1996;599-606